Guangdong Xianle Health Technology

Sirio Pharma, officially known as Guangdong Xianle Health Technology, is a leading global Contract Development and Manufacturing Organization (CDMO) for the dietary supplement and nutraceutical industry. Founded in 1993 and headquartered in Shantou, China, the company provides comprehensive R&D, manufacturing, and packaging services for a wide range of dosage forms, including softgels, gummies, tablets, and powders. Sirio Pharma serves major international health and wellness brands, offering specialized formulations for categories such as immunity, digestion, and beauty-from-within. The company is publicly traded on the Shenzhen Stock Exchange and has expanded its global reach through the acquisition of European and North American manufacturers like Ayanda and Best Formulations. With multiple GMP-certified facilities worldwide, Sirio Pharma is recognized for its innovation in delivery systems and high-quality production standards.